Search research articles
Contact Us
Filters
Showing results (761-770 of 780) with videos related to
Page
of 78
Sort By:
Tropical Medicine and Infectious Disease
|
September 27, 2023
Comparing Catastrophic Costs: Active vs. Passive Tuberculosis Case Finding in Urban Vietnam
Luong V Dinh, Anja M C Wiemers, Rachel J Forse, et al.
British Journal of Cancer
|
August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
B P Schneider, L Li, F Shen, et al.
European Heart Journal
|
February 22, 2023
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial
Jessica M Scott, Jasme Lee, James E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Sara M Tolaney, Hao Guo, Sonia Pernas, et al.
Nutrients
|
December 11, 2022
Osteoporosis Risk in Hemodialysis Patients: The Roles of Gender, Comorbidities, Biochemical Parameters, Health and Diet Literacy
Lan T H Le, Loan T Dang, Tsae-Jyy Wang, et al.
Theranostics
|
June 30, 2025
Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers
Cao Dai Phung, Trinh T T Tran, Brendon Zhi Jie Yeo, et al.
Nature Communications
|
July 12, 2025
Carbene formation as a mechanism for efficient intracellular uptake of cationic antimicrobial carbon acid polymers
Chong Hui Koh, Mallikharjuna Rao Lambu, Chongyun Tan, et al.
JCO Oncology Practice
|
May 30, 2020
InSight Care Pilot Program: Redefining Seeing a Patient
Bobby Daly, Gilad Kuperman, Alice Zervoudakis, et al.
The Lancet. Oncology
|
March 1, 2023
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
Sara M Tolaney, Paolo Tarantino, Noah Graham, et al.
Nature Communications
|
September 30, 2015
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
Harriet Corvol, Scott M Blackman, Pierre-Yves Boëlle, et al.
Page
of 78
Search research articles
Search
Showing results (761-770 of 780) with videos related to
Sort By:
Page
of 78
Tropical Medicine and Infectious Disease
|
September 27, 2023
Comparing Catastrophic Costs: Active vs. Passive Tuberculosis Case Finding in Urban Vietnam
Luong V Dinh, Anja M C Wiemers, Rachel J Forse, et al.
British Journal of Cancer
|
August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
B P Schneider, L Li, F Shen, et al.
European Heart Journal
|
February 22, 2023
Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial
Jessica M Scott, Jasme Lee, James E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Sara M Tolaney, Hao Guo, Sonia Pernas, et al.
Nutrients
|
December 11, 2022
Osteoporosis Risk in Hemodialysis Patients: The Roles of Gender, Comorbidities, Biochemical Parameters, Health and Diet Literacy
Lan T H Le, Loan T Dang, Tsae-Jyy Wang, et al.
Theranostics
|
June 30, 2025
Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers
Cao Dai Phung, Trinh T T Tran, Brendon Zhi Jie Yeo, et al.
Nature Communications
|
July 12, 2025
Carbene formation as a mechanism for efficient intracellular uptake of cationic antimicrobial carbon acid polymers
Chong Hui Koh, Mallikharjuna Rao Lambu, Chongyun Tan, et al.
JCO Oncology Practice
|
May 30, 2020
InSight Care Pilot Program: Redefining Seeing a Patient
Bobby Daly, Gilad Kuperman, Alice Zervoudakis, et al.
The Lancet. Oncology
|
March 1, 2023
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
Sara M Tolaney, Paolo Tarantino, Noah Graham, et al.
Nature Communications
|
September 30, 2015
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
Harriet Corvol, Scott M Blackman, Pierre-Yves Boëlle, et al.
Page
of 78